![Leticia Toledo-Sherman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leticia Toledo-Sherman
Corporate Officer/Principal chez
LymphoSign, Inc.
Profil
Leticia Toledo-Sherman has been Executive Director of Chemistry for LymphoSign, Inc. since August 2004.
Prior to joining LymphoSign, Inc, she was Director of Drug Design and Discovery for MDS Proteomics Inc. Dr. Toledo-Sherman worked for Kinetix Pharmaceuticals, Inc. She received a PhD in Organic Chemistry from The State University of New York.
Postes actifs de Leticia Toledo-Sherman
| Sociétés | Poste | Début |
|---|---|---|
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology Develops drugs for cancer treatment | Corporate Officer/Principal | 01/08/2004 |
Anciens postes connus de Leticia Toledo-Sherman
| Sociétés | Poste | Fin |
|---|---|---|
MDS Proteomics, Inc.
 MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Corporate Officer/Principal | - |
Kinetix Pharmaceuticals, Inc.
 Kinetix Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers small molecule drugs in the field of protein kinase inhibition | Corporate Officer/Principal | - |
Formation de Leticia Toledo-Sherman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
MDS Proteomics, Inc.
MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Commercial Services |
Kinetix Pharmaceuticals, Inc.
Kinetix Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers small molecule drugs in the field of protein kinase inhibition | Commercial Services |
LymphoSign, Inc.
LymphoSign, Inc. BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
